Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | US | 2018 | Market Analysis

The US market for aesthetic injectables will approach $3 billion by 2026, driven primarily by high patient demand, including from emerging patient groups such as men and younger individuals. New product types, such as fat reduction injectables, and the approval of expanded indications for existing products will also contribute to market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in the US across a 10-year period.

Related Medtech Insights Reports

Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will be driven by rising aesthetic consciousness, an aging population, and increasing demand for clinically validated skincare solutions. The…
Report
Breast Implants and Reconstructive Devices – Market Insights – Europe
The global breast implants and reconstruction device market will expand through 2034, supported by technological advancements and evolving product designs. Despite ongoing regulatory challenges and…
Report
Breast Implants and Reconstructive Devices – Market Insights – United States
The US breast implant and reconstructive device market is projected to grow steadily through 2034, driven by the rising incidence of breast cancer, established screening guidelines, and increasing…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – United States
The US physician-dispensed cosmeceuticals market will experience robust growth through the forecast period. The expansion is fueled by rising demand for aesthetic procedures, growing consumer…
Report
Aesthetic Energy-Based Devices – Market Insights – United States
Aesthetic energy-based device procedure volumes will be supported by the trend toward minimally invasive and noninvasive treatments. As a result, companies are investing in developing such devices…